Investment Analysts’ price target changes for Tuesday, September 24th:
Accenture (NYSE:ACN) had its price target lowered by JPMorgan Chase & Co. from $376.00 to $370.00. The firm currently has an overweight rating on the stock.
American Healthcare REIT (NYSE:AHR) had its target price increased by Bank of America Co. from $27.00 to $31.00. The firm currently has a buy rating on the stock.
Arista Networks (NYSE:ANET) had its price target increased by The Goldman Sachs Group, Inc. from $390.00 to $430.00. The firm currently has a buy rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target cut by Wells Fargo & Company from $47.00 to $43.00. Wells Fargo & Company currently has an equal weight rating on the stock.
ATS (TSE:ATS) had its target price cut by Stifel Nicolaus from C$60.00 to C$58.00. The firm currently has a buy rating on the stock.
Axos Financial (NYSE:AX) had its target price cut by Wedbush from $80.00 to $75.00. They currently have a neutral rating on the stock.
Acuity Brands (NYSE:AYI) had its target price boosted by Wells Fargo & Company from $260.00 to $289.00. The firm currently has an equal weight rating on the stock.
Boeing (NYSE:BA) had its target price lowered by The Goldman Sachs Group, Inc. from $232.00 to $202.00. They currently have a buy rating on the stock.
Biohaven (NYSE:BHVN) had its target price boosted by Bank of America Co. from $52.00 to $62.00. They currently have a buy rating on the stock.
Biohaven (NYSE:BHVN) had its price target raised by Sanford C. Bernstein from $55.00 to $66.00. They currently have an outperform rating on the stock.
Biohaven (NYSE:BHVN) had its price target increased by Royal Bank of Canada from $59.00 to $68.00. Royal Bank of Canada currently has an outperform rating on the stock.
BankUnited (NYSE:BKU) had its target price raised by Wedbush from $39.00 to $40.00. The firm currently has a neutral rating on the stock.
Braze (NASDAQ:BRZE) had its target price reduced by DA Davidson from $65.00 to $55.00. The firm currently has a buy rating on the stock.
Braze (NASDAQ:BRZE) had its target price reduced by TD Cowen from $52.00 to $45.00. TD Cowen currently has a buy rating on the stock.
Braze (NASDAQ:BRZE) had its price target cut by Oppenheimer Holdings Inc. from $60.00 to $51.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
B2Gold (NYSE:BTG) had its target price increased by CIBC from $3.30 to $3.60. They currently have a neutral rating on the stock.
Maplebear (NASDAQ:CART) had its price target boosted by Bank of America Co. from $41.00 to $45.00. Bank of America Co. currently has a neutral rating on the stock.
Maplebear (NASDAQ:CART) had its price target trimmed by Morgan Stanley from $45.00 to $41.00. They currently have an equal weight rating on the stock.
CAVA Group (NYSE:CAVA) had its price target raised by TD Securities from $115.00 to $130.00. The firm currently has a buy rating on the stock.
Cibus (NASDAQ:CBUS) had its target price reduced by Alliance Global Partners from $25.00 to $23.50. They currently have a buy rating on the stock.
Cameco (TSE:CCO) (NYSE:CCJ) had its target price raised by Canaccord Genuity Group Inc. from C$75.00 to C$78.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Celsius (NASDAQ:CELH) had its price target cut by Piper Sandler from $50.00 to $47.00. The firm currently has an overweight rating on the stock.
CF Industries (NYSE:CF) had its target price boosted by Wells Fargo & Company from $88.00 to $92.00. Wells Fargo & Company currently has an overweight rating on the stock.
Cullen/Frost Bankers (NYSE:CFR) had its price target lowered by Wedbush from $124.00 to $123.00. Wedbush currently has a neutral rating on the stock.
Chemtrade Logistics Income Fund (TSE:CHE.UN) had its target price raised by BMO Capital Markets from C$11.00 to C$12.00. BMO Capital Markets currently has an outperform rating on the stock.
Check Point Software Technologies (NASDAQ:CHKP) had its price target increased by Jefferies Financial Group Inc. from $210.00 to $225.00. They currently have a buy rating on the stock.
Cogent Biosciences (NASDAQ:COGT) had its target price increased by Citigroup Inc. from $13.00 to $15.00. The firm currently has a buy rating on the stock.
Compass (NYSE:COMP) had its price target increased by Oppenheimer Holdings Inc. from $6.00 to $8.00. They currently have an outperform rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its price target boosted by Jefferies Financial Group Inc. from $315.00 to $345.00. They currently have a buy rating on the stock.
CVB Financial (NASDAQ:CVBF) had its target price trimmed by Wedbush from $21.00 to $20.00. The firm currently has a neutral rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its target price raised by Jefferies Financial Group Inc. from $315.00 to $330.00. They currently have a buy rating on the stock.
Diversified Royalty (TSE:DIV) was given a C$4.00 price target by analysts at Ventum Financial. The firm currently has a buy rating on the stock.
Dunelm Group (LON:DNLM) had its target price boosted by JPMorgan Chase & Co. from GBX 1,140 ($15.27) to GBX 1,170 ($15.67). They currently have a neutral rating on the stock.
eBay (NASDAQ:EBAY) had its price target increased by Bank of America Co. from $57.00 to $65.00. Bank of America Co. currently has a neutral rating on the stock.
Ecopetrol (NYSE:EC) had its target price trimmed by The Goldman Sachs Group, Inc. from $11.00 to $9.50. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Essentra (LON:ESNT) had its price target lowered by Berenberg Bank from GBX 255 ($3.41) to GBX 200 ($2.68). The firm currently has a buy rating on the stock.
enCore Energy (CVE:EU) had its target price raised by Canaccord Genuity Group Inc. from C$8.00 to C$8.50. They currently have a buy rating on the stock.
Fission Uranium (TSE:FCU) had its target price cut by Canaccord Genuity Group Inc. from C$1.75 to C$1.65. They currently have a speculative buy rating on the stock.
F5 (NASDAQ:FFIV) had its target price raised by The Goldman Sachs Group, Inc. from $185.00 to $212.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Foghorn Therapeutics (NASDAQ:FHTX) had its price target increased by Morgan Stanley from $6.00 to $9.00. Morgan Stanley currently has an equal weight rating on the stock.
Foran Mining (CVE:FOM) had its price target raised by Stifel Nicolaus from C$4.75 to C$5.00. The firm currently has a buy rating on the stock.
FOX (NASDAQ:FOXA) had its price target boosted by Guggenheim from $44.00 to $45.00. The firm currently has a buy rating on the stock.
Global Atomic (TSE:GLO) had its target price cut by Canaccord Genuity Group Inc. from C$3.00 to C$2.75. Canaccord Genuity Group Inc. currently has a speculative buy rating on the stock.
Hanmi Financial (NASDAQ:HAFC) had its price target lowered by Wedbush from $22.00 to $21.00. They currently have a neutral rating on the stock.
Home Depot (NYSE:HD) had its price target raised by Oppenheimer Holdings Inc. from $345.00 to $400.00. Oppenheimer Holdings Inc. currently has a market perform rating on the stock.
Hawaiian Electric Industries (NYSE:HE) had its target price trimmed by Evercore ISI from $16.00 to $9.00. Evercore ISI currently has an in-line rating on the stock.
Hammond Power Solutions (TSE:HPS.A) had its target price increased by Acumen Capital from C$156.00 to C$160.00. They currently have a buy rating on the stock.
Hershey (NYSE:HSY) had its target price reduced by Barclays PLC from $204.00 to $202.00. The firm currently has an equal weight rating on the stock.
Hut 8 (NASDAQ:HUT) had its target price increased by Needham & Company LLC from $15.00 to $16.50. They currently have a buy rating on the stock.
IDEAYA Biosciences (NASDAQ:IDYA) had its price target reduced by Wedbush from $54.00 to $52.00. The firm currently has an outperform rating on the stock.
KeyCorp (NYSE:KEY) had its price target boosted by Wedbush from $17.00 to $18.00. They currently have a neutral rating on the stock.
Laboratory Co. of America (NYSE:LH) had its target price trimmed by Evercore ISI from $250.00 to $240.00. Evercore ISI currently has an in-line rating on the stock.
Li Auto (NASDAQ:LI) had its price target increased by Citigroup Inc. from $21.60 to $25.50. They currently have a neutral rating on the stock.
Light & Wonder (NASDAQ:LNW) had its price target cut by Susquehanna from $92.00 to $90.00. The firm currently has a neutral rating on the stock.
Lamb Weston (NYSE:LW) had its target price increased by TD Cowen from $61.00 to $65.00. The firm currently has a hold rating on the stock.
McDonald’s (NYSE:MCD) had its target price raised by The Goldman Sachs Group, Inc. from $284.00 to $325.00. The firm currently has a neutral rating on the stock.
Modine Manufacturing (NYSE:MOD) had its target price raised by DA Davidson from $140.00 to $155.00. The firm currently has a buy rating on the stock.
Mosaic (NYSE:MOS) had its price target reduced by Wells Fargo & Company from $29.00 to $27.00. They currently have an equal weight rating on the stock.
M&T Bank (NYSE:MTB) had its target price increased by Wedbush from $208.00 to $210.00. The firm currently has an outperform rating on the stock.
Okta (NASDAQ:OKTA) had its price target cut by Jefferies Financial Group Inc. from $100.00 to $85.00. Jefferies Financial Group Inc. currently has a hold rating on the stock.
Oxford Biomedica (LON:OXB) had its price target boosted by Deutsche Bank Aktiengesellschaft from GBX 250 ($3.35) to GBX 380 ($5.09). They currently have a hold rating on the stock.
Pacira BioSciences (NASDAQ:PCRX) had its target price boosted by Jefferies Financial Group Inc. from $15.00 to $18.00. They currently have a buy rating on the stock.
Public Service Enterprise Group (NYSE:PEG) had its target price raised by UBS Group AG from $87.00 to $94.00. UBS Group AG currently has a neutral rating on the stock.
Pacific Premier Bancorp (NASDAQ:PPBI) had its target price reduced by Wedbush from $28.00 to $27.00. Wedbush currently has a neutral rating on the stock.
Regeneron Pharmaceuticals (NASDAQ:REGN) had its target price cut by Royal Bank of Canada from $1,282.00 to $1,252.00. Royal Bank of Canada currently has an outperform rating on the stock.
Replimune Group (NASDAQ:REPL) had its target price raised by JPMorgan Chase & Co. from $14.00 to $17.00. The firm currently has an overweight rating on the stock.
Reinsurance Group of America (NYSE:RGA) had its target price increased by Raymond James from $228.00 to $250.00. The firm currently has a strong-buy rating on the stock.
SLM (NASDAQ:SLM) had its price target reduced by Wedbush from $29.00 to $26.00. They currently have an outperform rating on the stock.
Snowflake (NYSE:SNOW) had its target price cut by UBS Group AG from $155.00 to $125.00. UBS Group AG currently has a neutral rating on the stock.
Sable Offshore (NYSE:SOC) had its target price raised by Benchmark Co. from $24.00 to $37.00. The firm currently has a buy rating on the stock.
Constellation Brands (NYSE:STZ) had its target price raised by Barclays PLC from $295.00 to $309.00. They currently have an overweight rating on the stock.
Texas Capital Bancshares (NASDAQ:TCBI) had its target price raised by Wedbush from $70.00 to $77.00. Wedbush currently has a neutral rating on the stock.
Tourmaline Oil (TSE:TOU) was given a C$72.50 target price by analysts at National Bankshares, Inc.. The firm currently has a buy rating on the stock.
Spin Master (TSE:TOY) was given a C$46.00 target price by analysts at TD Securities. The firm currently has a buy rating on the stock.
Tripadvisor (NASDAQ:TRIP) had its price target reduced by Citigroup Inc. from $20.00 to $16.00. They currently have a neutral rating on the stock.
Union Pacific (NYSE:UNP) had its target price trimmed by Bank of America Co. from $273.00 to $270.00. They currently have a buy rating on the stock.
Uranium Royalty (TSE:URC) had its price target trimmed by Canaccord Genuity Group Inc. from C$6.75 to C$6.50. The firm currently has a speculative buy rating on the stock.
Valley National Bancorp (NASDAQ:VLY) had its target price increased by Wedbush from $9.00 to $10.00. They currently have a neutral rating on the stock.
Vistra (NYSE:VST) had its target price increased by Jefferies Financial Group Inc. from $99.00 to $137.00. Jefferies Financial Group Inc. currently has a buy rating on the stock.
Verizon Communications (NYSE:VZ) had its price target increased by Raymond James from $44.00 to $48.00. Raymond James currently has an outperform rating on the stock.
Western Alliance Bancorporation (NYSE:WAL) had its price target boosted by Wedbush from $90.00 to $105.00. Wedbush currently has an outperform rating on the stock.
Zevra Therapeutics (NASDAQ:ZVRA) had its price target increased by Maxim Group from $18.00 to $25.00. They currently have a buy rating on the stock.
Zevra Therapeutics (NASDAQ:ZVRA) had its target price increased by Roth Mkm from $19.00 to $21.00. Roth Mkm currently has a buy rating on the stock.
Receive News & Ratings for Accenture plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture plc and related companies with MarketBeat.com's FREE daily email newsletter.
